Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
New cancer therapy using genetically-engineered oncolytic Sendai virus vectorHiroaki Kinoh, Makoto Inoue
Accounts of Chemical Research|November 9, 2020
Tumor-Targeted Nanomedicine for ImmunotherapyHoracio Cabral, Hiroaki Kinoh, Kazunori Kataoka
Roux'S Archives of Developmental Biology : the Official Organ of the EDBO|March 18, 2017
Seasonal variations in the production of the egg-jelly macromolecule, a fucose sulphate glycoconjugate, by the accessory cells in the ovary of the sea urchin Hemicentrotus pulcherrimusHiroyuki Abe, Hiroaki Kinoh, Norio Suzuki
Development, Growth & Differentiation|June 7, 2023
Purification and Characterization of the Egg Jelly Macromolecules, Sialoglycoprotein and Fucose Sulfate Glycoconjugate, of the Sea Urchin Hemicentrotus Pulcherrimus: (sialoglycoprotein/fucose sulfate glycoconjugate/acrosome reaction/egg jelly/sea urchin spermatozoa)Takeshi Shimizu, Hiroaki Kinoh, Masaaki Yamaguchi, et al.
Roux'S Archives of Developmental Biology : the Official Organ of the EDBO|March 18, 2017
The egg-jelly macromolecule, a fucose sulphate glycoconjugate, originates from the accessory cells of the ovary in the sea urchin Hemicentrotus pulcherrimusHiroyuki Abe, Hiroaki Kinoh, Taneaki Oikawa, et al.
Roux'S Archives of Developmental Biology : the Official Organ of the EDBO|March 18, 2017
Expression of a putative precursor mRNA for sperm-activating peptide I in accessory cells of the ovary in the sea urchin Hemicentrotus pulcherrimusHiroaki Kinoh, Takeshi Shimizu, Hirotaka Fujimoto, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimenYoshikazu Yonemitsu, Yasuji Ueda, Hiroaki Kinoh, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimenYoshikazu Yonemitsu, Yasuji Ueda, Hiroaki Kinoh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 8, 2020
Nanomedicines blocking adaptive signals in cancer cells overcome tumor TKI resistanceHiroaki Kinoh, Hitoshi Shibasaki, Xueying Liu, et al.
ACS Nano|August 19, 2020
Translational Nanomedicine Boosts Anti-PD1 Therapy to Eradicate Orthotopic PTEN-Negative GlioblastomaHiroaki Kinoh, Sabina Quader, Hitoshi Shibasaki, et al.
Pageof 5